TY - JOUR
T1 - MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction
AU - Kocerha, Jannet
AU - Faghihi, Mohammad Ali
AU - Lopez-Toledano, Miguel A
AU - Huang, Jia
AU - Ramsey, Amy J
AU - Caron, Marc G
AU - Sales, Nicole
AU - Willoughby, David
AU - Elmen, Joacim
AU - Hansen, Henrik F
AU - Orum, Henrik
AU - Kauppinen, Sakari
AU - Kenny, Paul J
AU - Wahlestedt, Claes
N1 - Keywords: Animals; Behavior, Animal; Biological Transport; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Dizocilpine Maleate; Gene Expression Regulation; Gene Therapy; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Nervous System Diseases; Protein Subunits; RNA, Messenger; Receptors, N-Methyl-D-Aspartate; Signal Transduction
PY - 2009
Y1 - 2009
N2 - N-methyl-D-aspartate (NMDA) glutamate receptors are regulators of fast neurotransmission and synaptic plasticity in the brain. Disruption of NMDA-mediated glutamate signaling has been linked to behavioral deficits displayed in psychiatric disorders such as schizophrenia. Recently, noncoding RNA molecules such as microRNAs (miRNAs) have emerged as critical regulators of neuronal functions. Here we show that pharmacological (dizocilpine) or genetic (NR1 hypomorphism) disruption of NMDA receptor signaling reduces levels of a brain-specific miRNA, miR-219, in the prefrontal cortex (PFC) of mice. Consistent with a role for miR-219 in NMDA receptor signaling, we identify calcium/calmodulin-dependent protein kinase II gamma subunit (CaMKIIgamma), a component of the NMDA receptor signaling cascade, as a target of miR-219. In vivo inhibition of miR-219 by specific antimiR in the murine brain significantly modulated behavioral responses associated with disrupted NMDA receptor transmission. Furthermore, pretreatment with the antipsychotic drugs haloperidol and clozapine prevented dizocilpine-induced effects on miR-219. Taken together, these data support an integral role for miR-219 in the expression of behavioral aberrations associated with NMDA receptor hypofunction.
AB - N-methyl-D-aspartate (NMDA) glutamate receptors are regulators of fast neurotransmission and synaptic plasticity in the brain. Disruption of NMDA-mediated glutamate signaling has been linked to behavioral deficits displayed in psychiatric disorders such as schizophrenia. Recently, noncoding RNA molecules such as microRNAs (miRNAs) have emerged as critical regulators of neuronal functions. Here we show that pharmacological (dizocilpine) or genetic (NR1 hypomorphism) disruption of NMDA receptor signaling reduces levels of a brain-specific miRNA, miR-219, in the prefrontal cortex (PFC) of mice. Consistent with a role for miR-219 in NMDA receptor signaling, we identify calcium/calmodulin-dependent protein kinase II gamma subunit (CaMKIIgamma), a component of the NMDA receptor signaling cascade, as a target of miR-219. In vivo inhibition of miR-219 by specific antimiR in the murine brain significantly modulated behavioral responses associated with disrupted NMDA receptor transmission. Furthermore, pretreatment with the antipsychotic drugs haloperidol and clozapine prevented dizocilpine-induced effects on miR-219. Taken together, these data support an integral role for miR-219 in the expression of behavioral aberrations associated with NMDA receptor hypofunction.
U2 - 10.1073/pnas.0805854106
DO - 10.1073/pnas.0805854106
M3 - Journal article
C2 - 19196972
SN - 0027-8424
VL - 106
SP - 3507
EP - 3512
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 9
ER -